187 related articles for article (PubMed ID: 26366214)
1. Akt and Hippo Pathways in Ewing's Sarcoma Tumors and Their Prognostic Significance.
Ahmed AA; Abedalthagafi M; Anwar AE; Bui MM
J Cancer; 2015; 6(10):1005-10. PubMed ID: 26366214
[TBL] [Abstract][Full Text] [Related]
2. IGF1R immunohistochemistry in Ewing's sarcoma as predictor of response to targeted therapy.
Gonzalez E; Bui M; Ahmed AA
Int J Health Sci (Qassim); 2020; 14(4):17-21. PubMed ID: 32694968
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of SOX2 induces cell apoptosis and G1/S arrest in Ewing's sarcoma through the PI3K/Akt pathway.
Ren C; Ren T; Yang K; Wang S; Bao X; Zhang F; Guo W
J Exp Clin Cancer Res; 2016 Mar; 35():44. PubMed ID: 26969300
[TBL] [Abstract][Full Text] [Related]
4. CYP3A isoforms in Ewing's sarcoma tumours: an immunohistochemical study with clinical correlation.
Zia H; Murray GI; Vyhlidal CA; Leeder JS; Anwar AE; Bui MM; Ahmed AA
Int J Exp Pathol; 2015 Apr; 96(2):81-6. PubMed ID: 25670065
[TBL] [Abstract][Full Text] [Related]
5. Targeted morphoproteomic profiling of Ewing's sarcoma treated with insulin-like growth factor 1 receptor (IGF1R) inhibitors: response/resistance signatures.
Subbiah V; Naing A; Brown RE; Chen H; Doyle L; LoRusso P; Benjamin R; Anderson P; Kurzrock R
PLoS One; 2011 Apr; 6(4):e18424. PubMed ID: 21494688
[TBL] [Abstract][Full Text] [Related]
6. miR-185 suppresses progression of Ewing's sarcoma via inhibiting the PI3K/AKT and Wnt/β-catenin pathways.
Zhang S; Li D; Jiao GJ; Wang HL; Yan TB
Onco Targets Ther; 2018; 11():7967-7977. PubMed ID: 30519038
[TBL] [Abstract][Full Text] [Related]
7. Ezrin mediates growth and survival in Ewing's sarcoma through the AKT/mTOR, but not the MAPK, signaling pathway.
Krishnan K; Bruce B; Hewitt S; Thomas D; Khanna C; Helman LJ
Clin Exp Metastasis; 2006; 23(3-4):227-36. PubMed ID: 17028919
[TBL] [Abstract][Full Text] [Related]
8. Comparison of cell surface antigen HBA71 (p30/32MIC2), neuron-specific enolase, and vimentin in the immunohistochemical analysis of Ewing's sarcoma of bone.
Fellinger EJ; Garin-Chesa P; Glasser DB; Huvos AG; Rettig WJ
Am J Surg Pathol; 1992 Aug; 16(8):746-55. PubMed ID: 1497115
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor expression is up-regulated by EWS-ETS oncoproteins and Sp1 and may represent an independent predictor of survival in Ewing's sarcoma.
Fuchs B; Inwards CY; Janknecht R
Clin Cancer Res; 2004 Feb; 10(4):1344-53. PubMed ID: 14977835
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analysis and prognostic significance of PD-L1, PD-1, and CD8+ tumor-infiltrating lymphocytes in Ewing's sarcoma family of tumors (ESFT).
Machado I; López-Guerrero JA; Scotlandi K; Picci P; Llombart-Bosch A
Virchows Arch; 2018 May; 472(5):815-824. PubMed ID: 29445891
[TBL] [Abstract][Full Text] [Related]
11. Extraskeletal Ewing's sarcoma.
Ahmad R; Mayol BR; Davis M; Rougraff BT
Cancer; 1999 Feb; 85(3):725-31. PubMed ID: 10091746
[TBL] [Abstract][Full Text] [Related]
12. [Cooperative Ewing's Sarcoma Studies 81/86: pathologico-anatomic and immunohistochemical findings and differential diagnosis of Ewing sarcoma].
Schmidt D; Harms D
Klin Padiatr; 1988; 200(3):236-42. PubMed ID: 3062261
[TBL] [Abstract][Full Text] [Related]
13. Nucleophosmin as a candidate prognostic biomarker of Ewing's sarcoma revealed by proteomics.
Kikuta K; Tochigi N; Shimoda T; Yabe H; Morioka H; Toyama Y; Hosono A; Beppu Y; Kawai A; Hirohashi S; Kondo T
Clin Cancer Res; 2009 Apr; 15(8):2885-94. PubMed ID: 19351769
[TBL] [Abstract][Full Text] [Related]
14. Clinical and biological significance of hepatoma-derived growth factor in Ewing's sarcoma.
Yang Y; Li H; Zhang F; Shi H; Zhen T; Dai S; Kang L; Liang Y; Wang J; Han A
J Pathol; 2013 Nov; 231(3):323-34. PubMed ID: 23878072
[TBL] [Abstract][Full Text] [Related]
15. Ewing's sarcoma and primitive neuroectodermal tumor in adults: are they different from Ewing's sarcoma and primitive neuroectodermal tumor in children?
Verrill MW; Judson IR; Harmer CL; Fisher C; Thomas JM; Wiltshaw E
J Clin Oncol; 1997 Jul; 15(7):2611-21. PubMed ID: 9215832
[TBL] [Abstract][Full Text] [Related]
16. [Primitive cutaneous Ewing's sarcoma: a diagnostic and therapeutic dilemma].
Delaplace M; Mélard P; Perrinaud A; Goré C; Vergier B; Machet L
Ann Dermatol Venereol; 2011 May; 138(5):395-8. PubMed ID: 21570564
[TBL] [Abstract][Full Text] [Related]
17. Malignant peripheral neuroectodermal tumor and its necessary distinction from Ewing's sarcoma. A report from the Kiel Pediatric Tumor Registry.
Schmidt D; Herrmann C; Jürgens H; Harms D
Cancer; 1991 Nov; 68(10):2251-9. PubMed ID: 1655208
[TBL] [Abstract][Full Text] [Related]
18. Precursor B-Lymphoblastic lymphoma presenting as a solitary bone tumor and mimicking Ewing's sarcoma: a report of four cases and review of the literature.
Ozdemirli M; Fanburg-Smith JC; Hartmann DP; Shad AT; Lage JM; Magrath IT; Azumi N; Harris NL; Cossman J; Jaffe ES
Am J Surg Pathol; 1998 Jul; 22(7):795-804. PubMed ID: 9669342
[TBL] [Abstract][Full Text] [Related]
19. Ewing's sarcoma/peripheral primitive neuroectodermal tumor (ES/PNET) differentiation in endometrial serous carcinomas.
Quddus MR; Rashid L; Sung CJ; Steinhoff MM; Cunxian Zhang ; Lawrence WD
Reprod Sci; 2009 Jun; 16(6):591-5. PubMed ID: 19318687
[TBL] [Abstract][Full Text] [Related]
20. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.
Grier HE; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore S; Rausen AR; Vietti TJ; Miser JS
N Engl J Med; 2003 Feb; 348(8):694-701. PubMed ID: 12594313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
